Prof. Dr. Hans Peter Saluz, PhD is the contact person for scientific information, and information concerning use, safety and handling of the offered products ("Material Safety Data Sheets"), biological activities and toxicological properties of the products.
For special information concerning the selection system clonNAT (nourseothricin) and plasmid pYL16 ask for detailed descriptions.
Analysis of the nourseothricin-resistance gene (nat) of Streptomyces noursei.
Gene 62(2) (1988), 209-17.
In: BUSHELL, M. E., GRÄFE, U., (Eds.): Bioactive metabolites from microorganisms.
Progr. Ind. Microbiol., Amsterdam, 27 (1989), 357-367.
Sequence and transcriptional analysis of nourseothricin acetyltransferase-encoding gene nat-1 from Streptomyces noursei.
Gene 127 (1993), 127-131.
Three selectable markers for transformation of Ustilago maydis.
Gene 142 (1994), 225-230.
Large-scale essential gene identification in Candida albicans and application to antifungal drug discovery.
Molec. Microbiol. 50(1), (2003), 167-181.
Three New Dominant Drug Resistance Cassettes for Gene Disruption in Saccharomyces cerevisiae.
Yeast 15 (1999), 1541-1553.
Shuttle vectors for genetic manipulations in Ustilago maydis.
Can. J. Microbiology 46 (2000), 333-338.
Non-pathogenic trypanosomatid protozoa as a platform for protein research and production.
Prot. Express. Purific. 25 (2002), 209-218.
CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species.
Infection and Immunity, 73 (2) (2005) 1239-1242.
Application of the nourseothricin acetyltransferase gene (nat1) as dominant marker for the transformation of filamentous fungi.
Fungal Genetics Newsletter (2006) 53:9-11.